CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.0045 USD 12.5% Market Closed
Market Cap: 3m USD

Intrinsic Value

CPMD doesn't have a meaningful market cap.

The intrinsic value of one CPMD stock under the Base Case scenario is 0.0042 USD. Compared to the current market price of 0.0045 USD, CannaPharmaRx Inc is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CPMD Intrinsic Value
0.0042 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CannaPharmaRx Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CPMD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CPMD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CannaPharmaRx Inc.

Explain Valuation
Compare CPMD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CPMD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CannaPharmaRx Inc

Current Assets 1.2m
Cash & Short-Term Investments 17k
Receivables 137.5k
Other Current Assets 1m
Non-Current Assets 10.3m
Long-Term Investments 4.5m
PP&E 5.8m
Other Non-Current Assets 100
Current Liabilities 29m
Accounts Payable 5.5m
Accrued Liabilities 9.4m
Short-Term Debt 11.7m
Other Current Liabilities 2.3m
Non-Current Liabilities 5.1m
Other Non-Current Liabilities 5.1m
Efficiency

Free Cash Flow Analysis
CannaPharmaRx Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CannaPharmaRx Inc

Revenue
1.4m USD
Cost of Revenue
-3.5m USD
Gross Profit
-2.2m USD
Operating Expenses
-301.2k USD
Operating Income
-2.5m USD
Other Expenses
-3.2m USD
Net Income
-5.7m USD
Fundamental Scores

CPMD Profitability Score
Profitability Due Diligence

CannaPharmaRx Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
ROIC is Increasing
Exceptional ROE
Negative 3Y Average Gross Margin
33/100
Profitability
Score

CannaPharmaRx Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

CPMD Solvency Score
Solvency Due Diligence

CannaPharmaRx Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
28/100
Solvency
Score

CannaPharmaRx Inc's solvency score is 28/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CPMD Price Targets Summary
CannaPharmaRx Inc

There are no price targets for CPMD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

CannaPharmaRx Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CPMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CPMD stock?

The intrinsic value of one CPMD stock under the Base Case scenario is 0.0042 USD.

Is CPMD stock undervalued or overvalued?

Compared to the current market price of 0.0045 USD, CannaPharmaRx Inc is Overvalued by 6%.

Back to Top